Polivy 140 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FM1EB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,850
Award facts
- Contract value 100% obligated
- $34,849.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Polivy 140 mg vials, with a ceiling value of $34,849.74 and an ultimate completion date of January 15, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating that the award was made through open competition. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this delivery order is executed against AmerisourceBergen's substantial indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. Polivy (polatuzumab vedotin) is a specialized oncology therapeutic used in the treatment of certain lymphomas, reflecting the company's role in supplying specialty pharmaceuticals alongside generic medications, vaccines, and medical supplies to defense health agencies. The company's position as a federal pharmaceutical prime vendor demonstrates its capability to meet complex medical supply requirements across multiple therapeutic domains in support of the Defense Health Agency and broader military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FM1EB?
SPE2DR26FM1EB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26FM1EB worth?
The government has obligated $34,850 on SPE2DR26FM1EB.
Is contract SPE2DR26FM1EB an order under another contract?
Yes. SPE2DR26FM1EB is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM1EB competed?
The extent of competition for SPE2DR26FM1EB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award